These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7411984)

  • 21. [Metabolic and haemodynamic parameters during therapeutic starvation (author's transl)].
    Hartl O
    Wien Klin Wochenschr Suppl; 1976; 54():3-28. PubMed ID: 7883
    [No Abstract]   [Full Text] [Related]  

  • 22. [Fat consumption, blood lipids and age (author's transl)].
    Hunecke I; Reuter W
    Z Alternsforsch; 1979; 34(4):373-6. PubMed ID: 547519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of obesity with a liquid, relatively high protein diet (author's transl)].
    García de los Ríos M; Carrasco E; Padilla M; Fonseca B; López G
    Rev Med Chil; 1980 Aug; 108(8):691-6. PubMed ID: 7221255
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of primary hyperlipoproteinaemia types, IIa, IIb, 3 and IV with clofibrate (author's transl)].
    von Löwis P; Klemens UH
    Dtsch Med Wochenschr; 1973 Dec; 98(49):2328-33. PubMed ID: 4357927
    [No Abstract]   [Full Text] [Related]  

  • 25. Investigation of insulin sensitivity in early diabetes III. The effect of a combined physical training and diet programme on body weight, serum lipids and insulin sensitivity in obese asymptomatic diabetics.
    Ratzmann KP; Zander E; Witt S; Schulz B
    Endokrinologie; 1981 Apr; 77(2):233-41. PubMed ID: 7262046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Weight reduction by a high protein, low carbohydrate diet (author's transl)].
    Riegler E
    Med Klin; 1976 Jun; 71(24):1051-6. PubMed ID: 934003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of clofibrate on glucose tolerance and insulin secretion in patients with endogenous hypertriglyceridemia (author's transl)].
    Schwandt P; Weisweiler P; Neureuther G; Wilkening J
    MMW Munch Med Wochenschr; 1976 Mar; 118(12):351-4. PubMed ID: 177863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Relation between body fat distribution, insulin levels and glucose tolerance in obese females].
    Hauner H; Pfeiffer EF
    Klin Wochenschr; 1988 Mar; 66(5):216-22. PubMed ID: 3283431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elimination of the hyperlipidemia and proteinuria of genetically obese rats by hypophysectomy.
    Koletsky S; Snajdar RM
    Lab Invest; 1979 Oct; 41(4):287-93. PubMed ID: 491542
    [No Abstract]   [Full Text] [Related]  

  • 30. Insulin release in response to oral glucose in obesity: the effect of reduction of body weight.
    Farrant PC; Neville RW; Stewar GA
    Diabetologia; 1969 Jun; 5(3):198-200. PubMed ID: 5373821
    [No Abstract]   [Full Text] [Related]  

  • 31. [Exclusion of the small intestine in the treatment of extreme obesity (author's transl)].
    Husemann B
    Dtsch Med Wochenschr; 1973 Dec; 98(49):2343-7. PubMed ID: 4763876
    [No Abstract]   [Full Text] [Related]  

  • 32. [Relation of blood pressure to the body weight index and to metabolic parameters].
    Haller H; Leonhardt W; Moser W; Hanefeld M
    Z Gesamte Inn Med; 1973 Jul; 28(14):Suppl:211-3. PubMed ID: 4728091
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of weight reduction on obesity. Studies of lipid and carbohydrate metabolism in normal and hyperlipoproteinemic subjects.
    Olefsky J; Reaven GM; Farquhar JW
    J Clin Invest; 1974 Jan; 53(1):64-76. PubMed ID: 4357617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effects of a one-year weight reduction program and physical activity on obesity and comorbid conditions].
    Mijailović V; Micić D; Mijailović M
    Med Pregl; 2004; 57(1-2):55-9. PubMed ID: 15327191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum levels of pancreatic enzymes in lean and obese subjects.
    Kondo T; Hayakawa T; Shibata T; Sato Y; Toda Y
    Int J Pancreatol; 1988 May; 3(4):241-8. PubMed ID: 2455007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Changes in plasma lipids after baineological treatment (author's transl)].
    Zák A; Vinogradov S; Rublicová J; Krízek V; Stĕpánek P; Sadílek L
    Cas Lek Cesk; 1979 Jun; 118(25):771-5. PubMed ID: 498238
    [No Abstract]   [Full Text] [Related]  

  • 37. [Changes of serum lipids and changes of oral glucose load tests in obese persons].
    Radujkov Z; Nikolić L; Borojev A
    Med Pregl; 1976; 29(9-10):405-10. PubMed ID: 1004384
    [No Abstract]   [Full Text] [Related]  

  • 38. [Studies of insulinemia in obese patients].
    Jakubczyk D
    Rocz Akad Med Bialymst (1989); 1990-1991; 35-36():21-42. PubMed ID: 2136545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bromocriptine (Ergoset) reduces body weight and improves glucose tolerance in obese subjects.
    Cincotta AH; Meier AH
    Diabetes Care; 1996 Jun; 19(6):667-70. PubMed ID: 8725871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of weight loss on normal transaminase levels in obese patients.
    Uslan I; Acarturk G; Karaca E; Albayrak R; Yuksel S; Colbay M; Karaman O; Akcan Y
    Am J Med Sci; 2007 Nov; 334(5):327-30. PubMed ID: 18004085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.